Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
FDA’s pediatric adcomm votes to continue surveillance of 21 drugs, three vaccines
1 hour ago
FDA+
Federal judge sides with FDA on its mifepristone safety program
2 hours ago
FDA+
Law
J&J prevails in schizophrenia drug patent spat against Teva
3 hours ago
Pharma
Law
Q&A: Retiring Arvinas CEO John Houston talks PROTACs, investor confidence and what’s next with Pfizer
3 hours ago
People
CoRegen closes $93M financing round to enter the clinic and expand its leadership team
3 hours ago
Financing
Pharma
Novartis' brain delivery platform option deal worth up to $175M; Neumora's next steps
6 hours ago
News Briefing
Who pays the most in biopharma? We analyzed median pay at 177 companies
7 hours ago
Pharma
Trump’s CDC nominee Monarez advances to full Senate
7 hours ago
Pharma
Rhythm says oral rare obesity drug clears Phase 2 test, plans tweaks to formulation
9 hours ago
R&D
Revolution and Iambic to combine data and AI models in R&D deal for cancer drugs
9 hours ago
Deals
AI
AstraZeneca’s Alexion inks AAV capsid deal with JCR Pharma
10 hours ago
R&D
Cell/Gene Tx
Updated: Merck drops $10B for respiratory drugmaker Verona Pharma in its first acquisition of 2025
10 hours ago
Deals
Pharma
FDA approves new dosing of Lilly’s Alzheimer’s drug to lower brain swelling risks
10 hours ago
Pharma
Nimble radiopharma biotech Actithera gets $75M to enter the clinic
14 hours ago
Financing
Startups
Supreme Court halts California order that blocked RFK Jr. from reorganizing HHS
Yesterday
Law
'CRISPR Cures' center launches with $20M to make customized gene editing therapies
Yesterday
R&D
Cell/Gene Tx
Oura’s healthcare bet
Yesterday
Health Tech
Trump hints at tariff grace period for pharma companies to bring manufacturing to US
Yesterday
Pharma
Manufacturing
Otsuka’s Taiho reports Phase 3 fail for Duchenne muscular dystrophy drug
Yesterday
Pharma
In first half of 2025, novel drug approvals are in line with previous years
Yesterday
Pharma
FDA+
Recursion takes full rights to rare genetic disorder drug; CStone out-licenses cancer drug in Europe
Yesterday
News Briefing
Biopharma's 20 highest-paid CEOs of 2024 with $20M+ paydays
Yesterday
People
Pharma
ProKidney's stock shoots higher after mixed Phase 2 data
Yesterday
R&D
Quanterix closes Akoya deal after competing bid
Yesterday
Deals
Diagnostics
1
2
3
4
Next page
Last page
